Presbyopia pharmacological options widen past pilocarpine
Pilocarpine maturity, follow-on miotic-class programs, and emerging non-miotic mechanism programs are reshaping presbyopia management.
Presbyopia has been a reading-glasses, multifocal-contact-lens, and surgical-correction category. Pilocarpine ophthalmic solution provides a pharmacological reading-vision option, follow-on miotic-class programs (with reduced dim-vision side effects) are in late-stage trials, and emerging non-miotic mechanism programs targeting lens elasticity are reading out. The category is acquiring real pharmacotherapy after decades of optical-correction-only defaults.
Continue reading
Full intelligence on PanaceaIntel
PatientSpotlight publishes the headline framing. The full brief, the editorial takeaway, and the source list sit on PanaceaIntel for entitled clients.
New to PanaceaIntel? Request access and the team will reply within one working day.